Statistics
Publications
1
Citations
130
H-Index
1
Active since
2016
Affiliations
Dana-Farber Cancer Institute(Current)
N N Kabir is an author at Dana-Farber Cancer Institute specializing in flt3 inhibitors, chemotherapy resistance, and acute myeloid leukemia therapy.
Publications per year
2016–2016
1
1
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
Oscar Lindblad, Eugenia Cordero, Alexandre Puissant et al. · Oncogene · 2016 · 130 citations · Full text
Medicine, Oncology, Pharmacology +16
1–1 of 1